Develops and commercializes potentially improved versions of widely-prescribed drugs, designed to offer meaningful improvements in patient outcome through reduced side effects, increased efficacy, or improved dosage forms. (Nasdaq: SEPR).
Researching targeted therapies for cancer, neurodegenerative diseases, and neurofibromatosis. Find overviews, clinical trials and news. New York and California, USA.
Joining mailing list will entitle you
to receive occasional emails informing you of news and
updates to the site and any special offers that may be
of interest to you.